botics founder and CEO Alen York, expert in diabetes-related issues and CEO of Lyfebulb Dr. Karin Hehenberger, and the founder and former chairman of Human Genome Sciences and currently chairman of ACCESS Health International Dr. William A. Haseltine. Recommended by Forbes MOST POPULAR T TRENDING ON FACEBOOK The Insi

e view (trading +5%) Demand Media soared 20% on better than expected ql report as revs up & boosted 2012 outlook Glaxo to begin hostile offer for Human Genome Sciences (HGS1) at $13/share (HGSI closed $14.62) Green Mountain strips founder Robert Stiller of chairman role after stock sale to meet margin call NJ De